Jan 14, 2021 / 12:30PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning. I'm Chris Schott at JPMorgan. I'm very pleased to be introducing the newly formed Viatris for the company's first official presentation at the JPMorgan Healthcare Conference. We're going to have a presentation from the company's CEO, Michael Goettler, and then we're going to open up to a Q&A session with the broader management team from there. (Operator Instructions)
And with that, let me turn it over to Michael.
Michael Goettler - Viatris Inc. - CEO & Executive Director
All right. Good morning, Chris. Very nice to be back at JPMorgan, even though in a virtual format, and thanks for hosting us. And to the audience, I want to say thank you for joining us so early in the morning, East Coast time, 7 a.m., but for our first JPMorgan presentation as Viatris. A new kind of health care company that really came into being only 2 months ago.
What I would like to share with you today are really 3 topics. Number one, who is Viatris and give you a
Viatris Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot